Delivery Order SPE2DR25D2006-SPE2DR26F57RE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with a ceiling value of $12,540.76 and a firm fixed-price structure. The award was made on January 15, 2026, with an ultimate completion date of January 16, 2026, and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,643.44 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/mL vials, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.53 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dexamethasone 4 mg/mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,069.28 to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $1,139.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 23, 2026, with an ultimate completion date of January 26, 2026. This non-set-aside award was competitively procured and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Dexamethasone 4 mg tablets (100 count) with a ceiling value of $1,865.16. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, will be performed at the contractor's Conshohocken facility. The award was made without a set-aside designation,...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of dexamethasone 20 mg/5 ml vials. The $2,997.21 order is to be completed by January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,930.96 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57REDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 4 mg/ml vials with a contract ceiling value of $1,481.64. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by January 28, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare operations globally through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling federal pharmaceutical supply requirements through its extensive portfolio of delivery orders covering a wide spectrum of medications and medical commodities. This specific delivery order for dexamethasone, a corticosteroid medication used in military and veteran healthcare settings, exemplifies the routine pharmaceutical supply activities conducted under the company's master IDC with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/26/26 |